Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floor J Backes

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|May 15, 2018
Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survivalAshley S Felix, Jennifer A Sinnott, Monica Hagan Vetter, et al.
Gynecologic Oncology|June 29, 2024
Associations between race and ethnicity and treatment setting among gynecologic cancer patientsCaitlin E Meade, Jennifer A Sinnott, Floor J Backes, et al.
Gynecologic Oncology|November 15, 2024
Clinical trial enrollment during first course of gynecologic cancer treatment and survivalWafa Khadraoui, Jennifer A Sinnott, Caitlin E Meade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Real-world duration of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer in the United States: the CHAR1ZMA studyFloor J Backes, Tirza Areli Calderón Boyle, Jonathan Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Gynecologic Oncology|November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?Blair Smith, Georgia A McCann, Gary Phillips, et al.
The American Journal of Surgical Pathology|October 15, 2016
The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid AdenocarcinomasAmy S Joehlin-Price, Kelsey E McHugh, Julie A Stephens, et al.
Gynecologic Oncology|February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of MedicineDavid E Cohn, Floor J Backes, John J Wallbillich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2017
Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein DeficiencyZaibo Li, Amy S Joehlin-Price, Jennifer Rhoades, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|May 15, 2018
Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survivalAshley S Felix, Jennifer A Sinnott, Monica Hagan Vetter, et al.
Gynecologic Oncology|June 29, 2024
Associations between race and ethnicity and treatment setting among gynecologic cancer patientsCaitlin E Meade, Jennifer A Sinnott, Floor J Backes, et al.
Gynecologic Oncology|November 15, 2024
Clinical trial enrollment during first course of gynecologic cancer treatment and survivalWafa Khadraoui, Jennifer A Sinnott, Caitlin E Meade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Real-world duration of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer in the United States: the CHAR1ZMA studyFloor J Backes, Tirza Areli Calderón Boyle, Jonathan Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Gynecologic Oncology|November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?Blair Smith, Georgia A McCann, Gary Phillips, et al.
The American Journal of Surgical Pathology|October 15, 2016
The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid AdenocarcinomasAmy S Joehlin-Price, Kelsey E McHugh, Julie A Stephens, et al.
Gynecologic Oncology|February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of MedicineDavid E Cohn, Floor J Backes, John J Wallbillich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2017
Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein DeficiencyZaibo Li, Amy S Joehlin-Price, Jennifer Rhoades, et al.
Pageof 11